Skip to main content

Journal of Cancer Survivorship

Ausgabe 3/2022

Inhalt (21 Artikel)

Development of a survivorship screening tool in survivors of hematopoietic cell transplant

Jennifer A. Hydeman, Megan E. Pailler, Pamela D. Paplham, Michael A. Zevon

Additional medical costs of chronic conditions among adolescent and young adult cancer survivors

Ola A. Abdelhadi, Jill Joseph, Brad H. Pollock, Theresa H. M. Keegan

Open Access Rehabilitation

Evaluation of two strategies to implement physical cancer rehabilitation guidelines for survivors of abdominopelvic cavity tumors: a controlled before-and-after study

Charlotte IJsbrandy, Petronella B. Ottevanger, Winald R. Gerritsen, Wim H. van Harten, Rosella P. M. G. Hermens

Review

Racial/ethnic disparities in use of surveillance mammogram among breast cancer survivors: a systematic review

Pragati Advani, Shailesh Advani, Pratibha Nayak, Helena M. VonVille, Pamela Diamond, Jason Burnett, Abenaa M. Brewster, Sally W. Vernon

Open Access

Narrative recognition and identification: a qualitative pilot study into reading literary texts with advanced cancer patients

Albert Kamp, Zarah Bood, Michael Scherer-Rath, Yvonne Weeseman, Nirav Christophe, Henny Dörr, José Sanders, Mirjam Sprangers, Esther Helmich, Liesbeth Timmermans, Ellen van Wolde, Hanneke W. M. van Laarhoven

The impact of weight loss on physical function and symptoms in overweight or obese breast cancer survivors: results from POWER-remote

Jennifer Y. Sheng, Cesar A. Santa-Maria, Amanda L. Blackford, David Lim, Ashley Carpenter, Karen L. Smith, Gary I. Cohen, Janelle Coughlin, Lawrence J. Appel, Vered Stearns, Claire Snyder

Determinants of surveillance for late effects in childhood cancer survivors: a qualitative study using the Theoretical Domains Framework

Jennifer Shuldiner, Nida Shah, Ann Marie Corrado, David Hodgson, Paul C. Nathan, Noah Ivers

Use of complementary or alternative medicine and potential interactions with chronic medications among Chinese survivors of childhood cancer

Chun Sing Lam, Yi Man Cheng, Hoi Shan Li, Ho-Kee Koon, Chi Kong Li, Celeste L.Y. Ewig, Yin Ting Cheung

Examination of a distress screening intervention for rural cancer survivors reveals low uptake of psychosocial referrals

Pam Baker DeGuzman, David L. Vogel, Bethany Horton, Veronica Bernacchi, C. Allen Cupp, B. J. Ferrebee Ghamandi, Ivora D. Hinton, Christi Sheffield, Mark J. Jameson

Open Access

Return to work of breast cancer survivors: toward an integrative and transactional conceptual model

Bertrand Porro, Marie-José Durand, Audrey Petit, Mélanie Bertin, Yves Roquelaure

The association of stressful life events on weight loss efforts among African American breast cancer survivors

Jamila L. Kwarteng, L. Matthews, A. Banerjee, L. K. Sharp, B. S. Gerber, M. R. Stolley

Subjective cognition and mood in persistent chemotherapy-related cognitive impairment

Jennifer N. Vega, Kimberly M. Albert, Ingrid A. Mayer, Warren D. Taylor, Paul A. Newhouse

Health-related and cancer risk concerns among siblings of childhood cancer survivors: a report from the Childhood Cancer Survivor Study (CCSS)

Sonia Morales, Sedigheh Mirzaei Salehabadi, Deokumar Srivastava, Todd M. Gibson, Wendy M. Leisenring, Melissa A Alderfer, E. Anne Lown, Lonnie K. Zeltzer, Gregory T. Armstrong, Kevin R. Krull, David Buchbinder

Disparities in post-operative surveillance testing for metastatic recurrence among colorectal cancer survivors

Janeth I. Sanchez, Veena Shankaran, Joseph M. Unger, Margaret M. Madeleine, Noah Espinoza, Beti Thompson

Open Access

Increasing physical activity levels following treatment for cervical cancer: an intervention mapping approach

Nessa Millet, Hilary J. McDermott, Esther L. Moss, Charlotte L. Edwardson, Fehmidah Munir

Review

Interventions to address disparities and barriers to pediatric cancer survivorship care: a scoping review

Erin M. Mobley, Diana J. Moke, Joel Milam, Carol Y. Ochoa, Julia Stal, Nosa Osazuwa, Jai Kemp, Maria Bolshakova, Jennifer Dinalo, Aneesa Motala, Susanne Hempel

Forgoing needed medical care among long-term survivors of childhood cancer: racial/ethnic-insurance disparities

Jessica L. Baedke, Lauren A. Lindsey, Aimee S. James, I-Chan Huang, Kirsten K. Ness, Carrie R. Howell, Tara M. Brinkman, Nickhill Bhakta, Matthew J. Ehrhardt, Cindy Im, William Letsou, Qi Liu, Leslie L. Robison, Melissa M. Hudson, Yutaka Yasui

Promoting exercise for patients with multiple myeloma: attitudes and practices of clinical haematologists

Jennifer L. Nicol, Michelle M. Hill, Nicola W. Burton, Tina L. Skinner

Long-term neurocognitive and quality of life outcomes in survivors of pediatric hematopoietic cell transplant

Natalie L. Wu, Kevin R. Krull, Kara L. Cushing-Haugen, Nicole J. Ullrich, Nina S. Kadan-Lottick, Stephanie J. Lee, Eric J. Chow

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.